Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Economic aspects Newborn (0-1 years) Children (2-9 years) Rotavirus
Safety Administration Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Parents/caregivers Mumps Measles Rubella
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Administration Efficacy/effectiveness Newborn (0-1 years) Rotavirus
Adolescents (10-18 years) Adults (18+) vaccine safety Agenda & Minutes United States of America Herpes zoster Influenza Mumps Human papillomavirus Japanese encephalitis Pneumococcal disease
Download: